Bryophyllum vs. Nifedipine

Bryophyllum p. Versus Nifedipine for the Treatment of Premature Contractions

Status

UNKNOWN

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00391339

Enrollment

140

Registered

2006-10-23

Start date

2006-11-30

Completion date

2008-10-31

Last updated

2006-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tocolysis

Keywords

Bryophyllum p., Nifedipine, Tocolysis

Brief summary

In a prospective, randomised study the efficacy and tolerability of bryophyllum p. (p.o) vs. nifedipine (p.o) will be proofed in a defined group of pregnant women with threatened preterm labour.

Interventions

DRUGBryophyllum p.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* Female

Exclusion criteria

* Bishop Score \> 5

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026